• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Cigna, Express Scripts extend merger termination date

Share:

November 25, 2018

Cigna and Express Scripts have extended the termination date for their merger agreement by six months, with the original deadline just two weeks away.

In an SEC filing, Cigna notes the date has been extended to June 8, 2019, from an original Dec. 8, 2018.

But “Cigna and Express Scripts continue to anticipate that the transactions contemplated by the Merger Agreement will close in 2018, subject to the satisfaction of all closing conditions.”

Earlier, the NY Department of Financial Services planned a public hearing on the deal for Dec. 7 — the day before the original deadline.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Date: November 26, 2018

Source: Seeking Alpha

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Illumina Partners with Sequoia Capital China to Launch Genomics Incubator in ChinaIllumina Partners with Sequoia Capital China to Launch Genomics Incubator in China
  • Anokion Acquires Kanyos Bio And Raises $40 Million To Advance First Product Candidate Into Clinic In 2019Anokion Acquires Kanyos Bio And Raises $40 Million To Advance First Product Candidate Into Clinic In 2019
  • Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/prospectus to the Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/prospectus to the Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.
  • Heska Corporation Completes Acquisition of SCIL Animal Care to Create a Global Leader in Veterinary Point-of-Care DiagnosticsHeska Corporation Completes Acquisition of SCIL Animal Care to Create a Global Leader in Veterinary Point-of-Care Diagnostics
  • UK COVID-19 Tracing Policy Lag Cost Lives says Expert on App Development TeamUK COVID-19 Tracing Policy Lag Cost Lives says Expert on App Development Team
  • HHS Announces Interoperability Innovation Awardees For FHIR Scalability, Patient EngagementHHS Announces Interoperability Innovation Awardees For FHIR Scalability, Patient Engagement
  • Connected AED Company Avive Scores $22MConnected AED Company Avive Scores $22M
  • Memora, Luma Partner to Offer Health Systems a Wholesale Digital Front DoorMemora, Luma Partner to Offer Health Systems a Wholesale Digital Front Door

Trending This Week

  • New tools and acquisitions from OptumRx, ScionHealth.
  • In the wake of Dobbs, women’s health is ‘Ripe for investment’
  • Market Skeptical Following Sen. Warren’s Antitrust Allegations
  • Rogers, Shaw tick lower amid a report that Industry Minister in no hurry to Ok deal
  • ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, furthering its Ambition to Become the Global Leader in Regenerative Therapies
  • LGM Pharma Acquires Pharmaceutical Development and Manufacturing Unit of Nexgen Pharma

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications